Latest Articles
-
Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs of Around $75?
Gilead Sciences stock (NASDAQ: GILD) trades at $65 per share, about 11% below the level seen in December 2021. GILD stock was trading at around $62 in early June 2022, just before the Fed started increasing rates, and is still close to that l...
-
Should You Pick Estée Lauder Stock At $130?
Estée Lauder (NYSE: EL) reported Q3’24 results last week (the fiscal year ends in June) with revenue and earnings exceeding our expectations . The company’s revenues stood at $3.9 billion and earnings came in at $0.97, compared to our es...
-
Down 13% This Year, What’s Happening With Yelp Stock?
Yelp (NYSE: YELP), an online site for discovering local businesses ranging from bars, restaurants, and cafes, to hairdressers, spas, and gas stations, is scheduled to report its fiscal first-quarter results on Thursday, May 9. We expect the stock...
-
Up 6% Year To Date, What Lies Ahead For Tapestry Stock Post Q3 Results?
Note: Tapestry’s FY’23 ended July 1, 2023 . Tapestry (NYSE: TPR), a luxury goods retailer of handbags, shoes, and accessories, is scheduled to report its fiscal third-quarter results on Thursday, May 9. We expect the apparel retail...
-
With Analog Semiconductor Market Looking Up, Is Texas Instruments Stock Attractive At $182?
Texas Instruments (NASDAQ:TXN) stock has risen by just about 7% year-to-date, compared to the broader Nasdaq-100, which is up by almost 10% year-to-date. While the broader semiconductor industry has seen a recovery from a cyclical downturn in rec...
-
Will Colgate-Palmolive Stock See Higher Levels After Over A 15% Rise This Year?
Colgate-Palmolive (NYSE: CL) reported its Q1 results on April 26, with revenues and earnings above the street estimates. The company reported $5.1 billion revenue and $0.86 adjusted earnings per share, compared to the consensus estimates of $5....
-
Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?
Amgen stock (NASDAQ: AMGN) has seen a solid 9% rise in a week, outperforming the broader S&P500 index, up 1.5%. The recent rise can be attributed to the progress with its weight-loss drug — MariTide and its upbeat Q1 results reported last ...
-
Down 8% This Year, Will Beyond Meat Stock Recover Following Q1 Results?
Beyond Meat stock (NASDAQ: BYND), a plant-based meat alternative company, is scheduled to report its fiscal first-quarter results on Wednesday, May 8. We expect BYND’s stock to likely trade lower with revenues and earnings missing expecta...
-
With The Stock Flat This Year, Will Q3 Results Drive News Corp’s Stock Higher?
[Note: News Corp Fiscal Year Ends in June] News Corp stock (NASDAQ: NWSA), a global, diversified media and information services company, is scheduled to report its third-quarter results on Wednesday, May 8. We expect NWSA’s stock to see ...
-
Up 10% This Year, Does Johnson Controls Stock Still Have Room To Grow?
Johnson Controls stock (NYSE: JCI) reported its Q2 fiscal 2024 results last week (fiscal ends in September), with revenue marginally missing and earnings exceeding the street expectations. The company reported revenue of $6.70 billion and adjus...
-
How Are Qualcomm And Other Apple Suppliers Faring This Year?
Our Theme of Apple Component Supplier Stocks, which includes a diverse set of companies that supply components for Apple’s devices, has remained roughly flat year to date in 2024, underperforming the S&P 500 which remains up by 9% and compar...
-
Will Alibaba’s Cloud Business See A Turnaround In Q4?
Chinese e-commerce and cloud behemoth Alibaba stock (NYSE:BABA) is poised to report its Q4 FY’24 results on May 14th, reporting on a quarter that is likely to see the company’s business exhibit only modest growth, amid headwinds in th...
-
Is Pfizer Stock Fully Valued At $28?
Pfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates. The company reported revenue of $14.9 billion and an adjusted profit of $0.82 per share, compared to the consensus estimates of $14.0...
-
Gaining 20% This Year, Will Tripadvisor Stock Rally Further After Q1 Results?
Tripadvisor (NASDAQ: TRIP), an online travel company providing booking for hotel reservations, transportation, lodging, travel experiences, and restaurants, is scheduled to announce its fiscal first-quarter results on Wednesday, May 8. We expect...
-
With A Slowdown in Advertising, What To Expect From NY Times’ Q1 Results?
New York Times’ stock (NYSE: NYT), a diversified media company that includes newspapers, internet businesses, television, and radio stations, is scheduled to report its Q1 2024 results on Wednesday, May 8. We expect NYT stock to likely see...